PRDM1 and type 1 diabetes mellitus: By contrast, overexpression of Blimp-1 in T cells decreases the effector functions of Th1 and Th17 cells, thereby attenuating type 1 diabetes (T1D) in these Blimp-1–transgenic (BTg) NOD mice (6).